Order Article Reprints

Moujaes E, Dupont J, Lawrance L, Frau F, Jardali G, Dawi L, Kind M, Su C, Ammari S, Masri N, et al. The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma. Cancers. 2026; 18(1):20. https://doi.org/10.3390/cancers18010020

Moujaes, Elissar, Jules Dupont, Littisha Lawrance, Fiona Frau, Ghina Jardali, Lama Dawi, Michèle Kind, Caroline Su, Samy Ammari, Nohad Masri, and et al. 2026. "The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma" Cancers 18, no. 1: 20. https://doi.org/10.3390/cancers18010020

Moujaes, E., Dupont, J., Lawrance, L., Frau, F., Jardali, G., Dawi, L., Kind, M., Su, C., Ammari, S., Masri, N., Mihele, A. B., Boige, V., Pudlarz, T., Smolenschi, C., Valéry, M., Camilleri, G. M., Boilève, A., Ducreux, M., Lassau, N., & Hollebecque, A. (2026). The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma. Cancers, 18(1), 20. https://doi.org/10.3390/cancers18010020